INTRODUCTION
============

Hashimoto's encephalopathy (HE) is a rare and underdiagnosed illness with worldwide prevalence rates of 2 to 3 per 100000 \[[@ref1]\]. Globally, 130 cases have been reported \[[@ref1]\]. Pediatric cases are under-reported, probably as a result of frequent underdiagnosis \[[@ref2]\].

Eponym
------

Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) and encephalopathy associated with autoimmune thyroid disease (EAATD).

CASE VIGNETTE
=============

A 17-year old girl was admitted to our tertiary care psychiatric center with fever that lasted 1 week, a headache, bilateral blurred vision and psychosis (which included tactile hallucinations, visual hallucinations, persecutory and referential delusions). Three years prior to admission, she experienced a fever episode with a unilateral right visual acuity defect and right divergent squint, which was partially resolved with steroid treatment for three weeks. Physical examination findings revealed an enlarged thyroid, a short fourth toe on the left leg, a single transverse palmar crease in the right hand. No other neurological or eye findings were present. The fundus bore an old scar extending from the disc to the macula in her right eye with disc pallor. A mental status examination revealed visual hallucinations seeing monkeys and snakes running around. Delusions of persecution and reference were also present. PANS Scale (P-13; N-7; G-20; T-40). Informed consent has been provided by the family members.

The clinical differentials included inflammation, infectious, structural, traumatic, metabolic, genetic and neurodegenerative conditions including infectious and autoimmune enecephalitis.

Positive results included elevated anti-thyroid peroxidase (480 IU/mL) and anti-thyroglobulin (287 IU/mL) antibodies, a slit lamp examination revealed an old toxoplasma scar and visual evoked potentials of bilateral optic neuritis. The rest of the results in [Table 1](#T1){ref-type="table"} were normal.

###### 

Hashimoto's encephalopathy work up in our patient

  ----------------------------------- ----------------------------------------------------------------------------------
  Baseline blood investigations       Intracranial infections (blood borne virus screen, measles, and PCR for viruses)
  Thyroid function tests              Autoimmune
  CSF, EEG, and MRI brain             Karyotyping
  Inborn errors of metabolism         Wilsons work up, ceruloplasmin and slit lamp for KF rings
  USG abdomen for germ cell tumours   Tumour markers-AFP, Beta hCG
  ----------------------------------- ----------------------------------------------------------------------------------

AFP: alpha-fetoprotein, CSF: cerebrospinal fluid, EEG: electroencephalography, hCG: human chorionic gonadotropin, PCR: poly- merase chain reaction, USG: ultrasound guidance

She was diagnosed with HE and treated with intravenous methylprednisolone (1 g/day; tapered and discontinued after 1 month) and symptomatically treated with antipsychotics. Diagnosis was made based on positive antithyroid peroxidase antibodies and neuropsychiatric features. Complete resolution of psychoses was observed within 1 month, with normalization of the anti-thyroid antibody titers. The patient is currently doing well, as established at the many months of follow up.

DISCUSSION
==========

HE was first reported in 1966 by Lord Brain \[[@ref4]\]. It derives its name from Hashimoto's thyroiditis, which is accompanied by anti-thyroid antibodies causing central nervous system manifestations.

The proposed mechanisms include immune complex deposition (a complex of antigen and anti-thyroid antibody) in the brain vessel wall, causing vasculitis, which in turn, causes brain cell infarction \[[@ref1],[@ref5]\]. Direct brain cell injury occurs because of the presence of antibodies against NH2 terminal alpha enolase (NAE), a common antigen in the brain and endothelial cells of the vessel wall \[[@ref5]\].

HE is usually seen in the fifth decade of life, although a double peak has been described with the first peak around the second decade \[[@ref1]\]. Female individuals have a higher propensity to develop HE with a sex ratio of 4:1 \[[@ref1]\]. Onset of HE could be acute or subacute, with a progressive or relapsing-remitting course \[[@ref1]\]. Thyroid complications vary, with 55% of patients presenting with hypothyroidism \[[@ref1],[@ref3]\]. Clinical features are non-specific and are highlighted in [Table 2](#T2){ref-type="table"} and Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}. Acute presentations are mostly neurological, whereas chronic presentations are mostly psychiatric ([Table 3](#T3){ref-type="table"}) \[[@ref1]\]. Among the cases of acute psychosis, visual hallucinations have been reported with a frequency of approximately 90% \[[@ref4]\].

###### 

Neurological features of Hashimoto's encephalopathy \[[@ref1]\]

  -------------------------------
       Neurological features
  -------------------------------
  1\. Encephalopathy\
   Diffuse hyperreflexia (85%)\
   Tremors\
   Myoclonus/seizures

  2\. Cerebellopathy-ataxia

  3\. Isolatedmyelopathy
  -------------------------------

![Psychiatric manifestations in Hashimoto's encephalopathy \[[@ref3]\].](JKACAP_30_042_fig_1){#F1}

![Comparision of psychiatric features of Hashimoto's encephalopathy in 2 Indian studies \[[@ref6]\].](JKACAP_30_042_fig_2){#F2}

###### 

Neuropsychiatric presentations in Hashimoto's enceph- alopathy

     Acute (25%)                               Chronic (75%)
  ----------------------------------------- -------------------------
  Seizures (\>95%)                          Cognitive deterioration
  Stroke (\>65%)                            Depression
  Acute encephalopathy                      Tremors
  Psychosis (visual hallucinations \>90%)   Myoclonus

Typical symptoms of HE in our patient included acute presentation of fever, visual hallucinations, acute encephalopathy, and recurrent stroke lasting for a short period of time. Typical manifestations included an enlarged thyroid gland, bilateral blurred vision, altered mental status, and visual hallucinations. An atypical observation included progression of psychosis to referential delusions.

HE is a diagnosis of exclusion as there is a lack of well-defined criteria for diagnosis or treatment. Organic etiologies need to be ruled out, as highlighted in the case section. Our clinical suspicion was high given the severity of symptoms (recurrent eye strokes with psychosis) and the presence of an enlarged thyroid gland (despite normal thyroid functions). The combination of thyroid disorder and neuropsychiatric symptoms led us to further investigate with anti-thyroid antibodies.

Other rare presentations of acute psychosis include conditions like neuropsychiatric manifestations of Japanese encephalitis, voltage gated potassium channel encephalitis, megaloencephalopathy leukoencephalopathy.

[Table 4](#T4){ref-type="table"} highlights the complete panel of investigations that aided in diagnosis. Note that the most specific marker thus far is the anti-NAE antibody, with a specificity of around 91%, and it is currently only used in research settings \[[@ref4]\].

###### 

Investigations in Hashimoto's encephalopathy \[[@ref1],[@ref3],[@ref5]\]

                                                     Varied, hypothyroidism commoner \[[@ref1],[@ref5]\]
  -------------------------------------------------- ---------------------------------------------------------------------------------------------
  TFT                                                
   Thyroid peroxidase antibodies                     \>1000 IU/L, not a specific marker, epiphenomenon of another autoimmune process \[[@ref4]\]
   Anti NAE antibodies Specificity 91% \[[@ref5]\]   
   CSF                                               Elevated proteins, lymphocytes \[[@ref1]\]
   EEG                                               Diffuse slowing (most common) \[[@ref1]\]
   MRI                                               Nonspecific \[[@ref1]\]
   MRA                                               Narrowing of cerebral blood vessels \[[@ref1]\]

CSF: cerebrospinal fluid, EEG: electroencephalography, NAE: NH2 terminal alpha enolase, MRA: MR angiography, TFT: thyroid function test

Treatment mainly includes the use of immunomodulators, of which glucocorticoids are the most commonly used \[[@ref1]\]. Other uses of agents such as azathioprine and methotrexate have been reported \[[@ref1]\]. Furthermore, treatment with plasmapheresis has also been tested. Acute encephalopathies respond rapidly to immunomodulators \[[@ref4]\]. In the event of acute strokes, appropriate treatment for strokes must be ensured. The use of corticosteroids for acute stroke remains controversial, probably because steroid treatment does not reverse stroke \[[@ref1]\]. Long term treatment with steroids is proposed as a prophylactic treatment; however, the long-term side effects of steroids need to be considered when contemplating the use of prophylactic agents \[[@ref1]\].

CONCLUSION
==========

HE is diagnosed more often in autoimmune clinics and tertiary centers and less commonly in an outpatient psychiatric clinic during its initial presentation. We recommend clinicians to have a high index of suspicion for 1) young onset psychosis, follow up on clinical and laboratory thyroid tests and if abnormal explore autoimmune pathology. 2) severe presentation include neurological features pointing to enecephalitis. A simplistic diagnostic triad includes neuropsychiatric features, elevated anti thyroid antibodies, and response to steroids. Early identification is crucial for a favorable prognosis, as the disease is completely reversible with appropriate treatment.
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